Vaccinating PLWH traveling to endemic regions, especially those at risk of experiencing a severe course of infection, such as newly diagnosed and/or treatment-naive PLWH, and particularly those with a CD4+ count of 200 cells/mm3 or lower, is crucial for preventing the cross-border spread of infections and minimizing the risk of severe illness and death. The gene discussed is CD4; the disease is infection.